2007年12月29日星期六
Vonage to Pay AT&T in Patent Dispute
Microsoft Expands Security Reporting
2007年12月28日星期五
Glitch in Windows Home Server Corrupts Files
2007年12月27日星期四
2008: Year of Innovation, Both Good And Evil
AMD and Intel: All in with the chips The biggest hardware challenge in 2008 undoubtedly will be the continuing fight between the two vendors whose CPUs power virtually all of our computers: Intel and AMD. Until 2003, Intel was in a solid and somewhat complacent leading position, while AMD was a distant second with chips that were rarely competitive to Intel's top of the line. That all changed in 2003 with the introduction of 64-bit chips, and later dual-core chips on the desktop and the Opteron server processor. In four years, AMD went from having no major OEMs to all of them. That's quite a reversal. When the Opteron came out, not one server vendor was a licensee -- and there aren't a lot of server vendors out there. Today, you can buy an IBM System x, an HP ProLiant, a SunFire or Dell PowerEdge servers with AMD Opteron chips. Veteran semiconductor market analyst Nathan Brookwood of Insight64 puts AMD's market share at just about 50 percent of retail, with slightly more than half in desktops and less than half in notebooks. "That's a huge move from where they were, and it's not all the low-priced stuff," he said. It was this success that proved AMD's undoing. In short, it grew faster than it could handle, sort of like a teenager still trying to fit into its pre-teen clothes. It couldn't produce enough product to satisfy demand when it added Dell as a customer in 2006 and the company got creamed in late '06 and into '07, and spent the year recovering. Getting its production capacity in line has been AMD's goal this year. Its problem wasn't creating chips -- it was making them. The massive Dresden, Germany plant had to be converted from 65-nanometer designs to 45nm, and at the same time upgrade from 200mm to 300mm wafers. Oh, and it also had to get the Quad-Core Opteron, a.k.a. "Barcelona," out the door. A daunting plan for a company a fraction of Intel's size with nowhere near its resources. AMD has an ace up its sleeve with ATI. The $5.4 billion acquisition to date has been more of a drag on the company, but benefits are finally starting to show, beginning with the "Spider" platform. AMD has the advantage over Intel and Nvidia, its chief rival to ATI, in that it can put together a complete PC platform with all of the chips needed. Going into 2008, AMD's challenge then is chiefly about getting to 45nm chip designs and shipping "Shanghai," the successor to Barcelona. Shanghai will supplant the quad-core Opteron CPU with a new 45nm process and 6MB of L3 cache, which is shared among its cores. Barcelona has only 2MB of L3 cache. "They darn well better get their 45nm products up and running and out on a more timely basis than they did with Barcelona," Brookwood said. "It's important because AMD needs Shanghai to compete with %26#91;Intel's upcoming%26#93; 'Nehalem.' If AMD does not have Shanghai to compete with Nehalem, then it will have a serious competitive problem." Like AMD, its daunting rival has not performed flawlessly company in the past, either -- although most of Intel's pain had been limited to 2006. For the world's largest chipmaker, 2007 was a year of increasing momentum. CEO Paul Otellini has cleaned house of all the bad old ideas, consolidated, cut and streamlined anywhere and everywhere to make Intel more efficient and very profitable. The challenge in 2008 for Intel is rather simple: don't screw up. With its scale and massive resources, the task may seem easy for Intel. But the company is taking a sizable risk with Nehalem. The design, when it ships later in the year, will finally mark Intel's dumping of the front-side bus -- the external memory controller that all data must pass through when entering or exiting the CPU. Abandoning the front-side bus should mean increased bandwidth. However, doing so requires a whole new architecture, new chipsets, new motherboards and a new way to handle memory. "This means changes across the board, it's not just a chip update," Brookwood said. "Platform and processor change should not be underestimated." Next page: Innovations in viruses and cybercrime? You'd better believe it.
Political Web: A Promise Not Yet Fulfilled
Source: Compete, Inc. Yet according to the latest poll from NBC and the Wall Street Journal (available in PDF format), only 4 percent of Republicans would nominate Paul to run for the party. By comparison, Giuliani comes in at 20 percent and Huckabee at 17 percent. Evidently, Internet popularity does not yet translate into real-world popularity. The candidates know it, too. That's why they're keeping their ad money off the Internet and spending it on TV, according to Campaign Media Analysis Group, a division of TNS Media Intelligence. Though spending on campaign advertising should reach $3 billion in 2008, the online portion "will amount to little more than a rounding error when put next to the money spent on television," advertising analyst Evan Tracey told the Wall Street Journal earlier this month. "If any business had to run on a cycle where you could only get your customers once every other year, and you had one day when they had to pick between your brand and somebody else's and whichever brand had 51 percent of the market won, you would want to have a medium that is best situated to essentially drive up the volume and get ... customers to notice you," Tracey said. "That has always been television." Next page: So will candidates be using the Internet at all in 2008?
2007年12月22日星期六
Malware Now Hiding As Google Toolbar Buttons
2007年12月21日星期五
2007: Open Source, Patents, SCO, And More
It is in charge of IRF1310N IRF1310NS to supply an effect
http://miede.109876543210.cn/r/It-is-in-charge-of-IRF1310N-IRF1310NS-to-supply-an-effect-FigUnMJG/
2007年12月20日星期四
A New Generation of Web Savvy 'Super-Communicators'
2007年12月19日星期三
Budget Cuts Imperil Fermilab
By Adrian Cho
ScienceNOW Daily News
19 December 2007
The budget decisions, part of a $550 billion omnibus spending package that Congress approved this week, call into question the U.S.'s commitment to particle physics as a whole, says Fermilab Director Pier Oddone. "There's a policy question for the government and for Congress," he says. "Do we want to stay in particle physics or not?"
The omnibus bill, passed nearly 3 months into the 2008 fiscal year, funds every federal agency outside the Defense Department. Bowing to a demand by President George W. Bush to trim domestic spending, the Democratic Congress sliced $22 billion from an earlier spending blueprint. That step meant steep cuts across the government, including a proposed double-digit boost for DOE's $3.8 billion Office of Science that funds Fermilab. As a result, the 8%26#37; increase that the lab was expecting for 2008 suddenly turned into a 10%26#37; cut from current levels. That $62 million turnaround (from $372 million to $310 million) specifically targets projects that are key to Fermilab's future.
One is a neutrino experiment known as NO?A, which would have been the lab's flagship experiment after its Tevatron collider shuts down. Researchers had expected $36 million in funding to start assembling the experiment this year; instead, Congress flat-lined the budget for the program, for which Fermilab spent $16 million last year.
Congress also cut funding for the proposed International Linear Collider (ILC)--a 30-kilometer-long multibillion-dollar behemoth that U.S. researchers hope someday to build at Fermilab (Science, 9 February, p. 746). Congress reduced funding for ILC research and development from a requested $60 million to $15 million. It also cut funding for research on superconducting accelerator technology from a projected $24 million to $5 million. Fermilab's share of those two pots shrunk accordingly, from an expected $47 million to $15 million. As the fiscal year is a quarter over, physicists have already spent nearly that much, so work will stop immediately, Oddone says. "These cuts rain down devastation on all these future programs," he says.
The cuts may also affect Fermilab's flagship Tevatron collider, which researchers hope will cough up the long-sought Higgs boson before it is nabbed by the more powerful Large Hadron Collider. The LHC will swing into action next summer at the European particle physics lab, CERN, near Geneva, Switzerland. To meet the new budget, employees will have to take unpaid leave, although Oddone says he hopes a "rolling furlough" program will allow him to keep the machine running.
The cuts undermine Fermilab's plan to move into neutrino research in the next several years and then, before the end of the next decade, play a leading role in the ILC. Some observers say that the cuts threaten the lab's very existence. "This sets Fermilab on a trajectory for closure after 2011," says Michael Lubell, director of public affairs for the American Physical Society in Washington, D.C. Barry Barish, a physicist at the California Institute of Technology in Pasadena and leader of the ILC Global Design Effort, says that project is in better shape, despite a 75%26#37; cut in the U.S. contribution to its budget, than is Fermilab. "Their problems dwarf ours," Barish says. "Fermilab is in deep, deep, deep trouble."
Related site
2007年12月18日星期二
Tropics on the Move
By Phil Berardelli
ScienceNOW Daily News
3 December 2007
The tilt of Earth's axis creates the tropical zones, which form a 47%26deg;-latitude belt around the planet's midsection. Also helping form these warm-weather regions are the distribution of water, land, winds, and currents. These processes take warm, moist air from the equator and send it toward the poles, where it raises temperatures in regions such as most of Central and South America, central and southern Africa, Southeast Asia, and a good bit of Australia. Climate models predict that global warming could be causing the tropics to expand. So far, they have suggested a creep of 2%26deg; of latitude north and south, but only over the next century.
To find out what has happened so far, a team led by climate scientist Dian Seidel of the National Oceanic and Atmospheric Administration in Silver Spring, Maryland, examined the stratosphere for signs of change in the tropics. She and colleagues surveyed five sets of data collected by satellites and weather balloons from 1979 to 2000. The data showed that tropical climate patterns, such as increased ozone concentrations and temperatures, in the stratosphere had expanded by up to 4.5%26deg; of latitude--depending on the observations--in the Northern Hemisphere during that short period.
Seidel says the reason for the difference between the model predictions and the observed data could be that the models tend to concentrate on the lower atmosphere and Earth's surface, not on the interactions with the stratosphere. Although the changes there are indeed occurring, "we don't know yet what that means for the surface," says Seidel, whose team reported the findings online 2 December in Nature Geoscience.
Atmospheric scientist John Wallace of the University of Washington, Seattle, says the survey "makes a compelling case that the tropical belt has widened substantially over the past 30 years," and if it continues at the same rate, "it will have major societal implications."
Fibre Channel Over Ethernet Goes Open Source
Who's Doing All The Ego Surfing?
2007年12月17日星期一
IBM Reels In Cajasol
UK Admits Losing Data Of 3 Million People
Apple Launch Of Leopard OS Its Best Ever: Report
2007年12月15日星期六
Supply the life again of old and useless plastics of strenghthened type of 90 energy-efficient, the
http://machinery.jijiwaiwai.com/r/Supply-the-life-again-of-old-and-useless-plastics-of-strenghthened-type-of-90-energyefficient-the-plastic-granulator-CVR8HR8y/
2007年12月13日星期四
Stem Cells Overpower Muscle Disease
By Steve Mitchell
ScienceNOW Daily News
12 December 2007
Duchenne muscular dystrophy, which predominantly strikes boys, is caused by a mutation in the gene for a protein called dystrophin that is essential for proper muscle function. The condition leads to muscle degeneration, and patients usually die in their 30s. A particular type of stem cell found in muscle can give rise to new muscle tissue, so a team led by geneticist Luis Garcia of G%26eacute;n%26eacute;thon, a nonprofit biotechnology firm in %26Eacute;vry, France, investigated whether these cells could be used to reverse the dystrophin problems.
The researchers first obtained the stem cells from patients via a muscle biopsy. Next, they used a virus to insert a gene into the cells that corrects the mutation in the dystrophin gene. The researchers then injected the modified stem cells into arteries of the legs of mice with muscular dystrophy. In just 3 weeks, muscles in the foot, shin, and thigh began expressing human dystrophin protein, indicating that the stem cells had given rise to muscle cells that had taken up residence in the muscles of the mice.
The real proof came in treadmill tests. The treated mice were able to run longer, maxing out at 15 minutes, than untreated ill animals, which managed only 10 minutes before becoming exhausted, the researchers report.
Garcia says his team now plans to test the strategy in people with muscular dystrophy. He adds that the technique could be used to treat a variety of genetic diseases, including other muscle and skin disorders.
Stem cell scientist Robert Lanza of Advanced Cell Technology in Worcester, Massachusetts, calls the strategy promising. He adds that the stem cells used in the study have advantages over reprogrammed skin cells, including eliminating the tricky business of inducing the cells to become muscle cells, but he notes that both types of cells could pose risks because the virus used to modify them could cause cancer.
Geneticist Kay Davies of the University of Oxford, U.K., says that in order for the approach to be successful in humans, the stem cells will have to be delivered to every muscle. That could prove an enormous challenge, she notes, because of the repeated injections and high costs involved.
2007年12月12日星期三
NetSuite IPO Auction Under Way
2007年12月10日星期一
Obesity Is Bacteria's Little Helper
By Steve Mitchell
ScienceNOW Daily News
10 December 2007
Obesity raises the risk for developing several serious conditions, including heart disease, diabetes, and certain cancers, and a growing body of evidence indicates that it also impairs the immune system. Earlier this year, a study in mice found that obese animals had more trouble fighting viruses, and previous research in people suggests that obesity suppresses key components of the immune system that help wipe out germs. Now a team led by oral biologist Salomon Amar of Boston University has shown for the first time that obesity also appears to reduce the immune system's ability to thwart bacteria.
The first thing the researchers needed to do was to plump up some mice. Five mice fed a calorie-laden, high-fat diet for 16 weeks bloated to 42 grams, or 1.5 times the weight of animals dining on standard mouse chow. Then, the researchers wrapped a silk thread soaked in a solution containing the bacteria Porphyromonas gingivalis, which cause gingivitis, around a tooth of each mouse to cause gum-disease infection. Compared to lean animals, the obese mice experienced 40%26#37; more bone loss around the roots of their teeth within 10 days after infection and had higher levels of bacteria in their plaque.
Further experiments showed that the obese mice had lethargic immune systems. When the researchers injected the gingivalis bacterium into the animals' tails, lean mice bumped up immune system components that respond to infections, including tumor necrosis factor-%26alpha; and interleukin-6. This response was blunted in obese mice. The researchers report their findings online this week in the Proceedings of the National Academy of Sciences.
How obesity impairs the immune system is not yet clear, but infectious disease researcher Herbert Tanowitz of Albert Einstein College of Medicine of Yeshiva University in New York City suggests that the chronic low-level inflammation that occurs as a result of obesity may somehow be at fault.
Periodontist microbiologist Robert Genco of the University at Buffalo in New York state says the findings raise the possibility that another immune system component, neutrophils, is also suppressed in obesity. Neutrophils, which were not monitored in this study, kill bacteria, so if these cells are compromised, more severe disease could develop, he says.
Tanowitz adds that obese people probably have the same impaired immune response, a serious concern because gum disease can lead to tooth loss and raise the risk of heart disease and stroke. "There is good evidence that people who are obese have more problems, at least in the hospital setting, with bacterial infections," he says.
Human Evolution Is Speeding Up
By Ann Gibbons
ScienceNOW Daily News
10 December 2007
In the current study, a team of researchers led by paleoanthropologist Henry Harpending of the University of Utah in Salt Lake City analyzed DNA from 270 individuals in the International HapMap Project, an effort to identify variations in human genes that cause disease. The team searched for single-nucleotide polymorphisms (SNPs)--mutations in an allele that spread throughout a population--and scanned sequence data from Europeans, Africans, and Asians. The researchers searched for SNPs that were flanked by tens of thousands of bases of identical DNA in many individuals in a population, because this suggests that the mutation is advantageous and under recent selection pressure to be preserved in a lineage.
Evolution has accelerated in 1800 human genes, which encompass about 7%26#37; of the human genome, Harpending's team reports online this week in the Proceedings of the National Academy of Sciences. Most of the mutations resulted from dramatic population booms, they suggest. As populations expand, the number of mutations increases, boosting the chances for a beneficial genetic variant that can improve survival and sweep through a population (in the same way that a large population of insects develops a gene for resistance to a pesticide faster than a small population).
Although the researchers don't know the identity of most of the genes, they say quite a few appear to be responses to changes in diet and a new wave of virulent diseases that swept through human populations as they began farming. Some examples include mutations that allow adults to digest starch, fatty acids, and lactose in milk, including mutations that arose in Europeans. Others improve the resistance to diseases, such as malaria, AIDS, and yellow fever in Africans. Several genes related to the production of human sperm also have been under selection in the past 10,000 years. Overall, "the pace of change has accelerated a lot in the last 40,000 years, especially since the end of the Ice Age," says Harpending.
The findings are persuasive to anthropologist Clark Larsen of Ohio State University in Columbus. But not everyone is on board. "I don't deny recent rapid selection," says geneticist Kenneth Kidd of Yale University. "But I am not yet convinced that so much rapid selection at so many places in the genome has occurred. ... I think we need much more data."
Palm's Woes Continue as Rivals Enjoy Successes
2007年12月7日星期五
Methylating the Mind
By Elizabeth Quill
ScienceNOW Daily News
7 December 2007
It takes more than genes to make people who they are. Identical twins, for example, can look and act differently even though they share the same DNA (ScienceNOW, 5 July 2005). Environmental factors likely contribute to this variation, but it also seems to depend on so-called epigenetic phenomena, activity that regulates genes without changing the DNA code (ScienceNOW, 12 April 2006). In the 1960s, researchers found that the addition of a molecule called a methyl group to cytosine, one of the four building blocks of DNA, could turn off genes. Since then, scientists have found that this process, called methylation, can also turn genes on and that it is linked to cancer (ScienceNOW, 31 January 2000) and short-term memory formation (ScienceNOW, 14 March).
Because no studies have surveyed methylation's role in assigning marching orders to brain cells, geneticist Andrew Feinberg and psychiatric neuroscientist James Potash, both of Johns Hopkins University in Baltimore, Maryland, decided to investigate. Along with their colleagues, they compared possible methylation sites on 807 genes in 76 samples from human brains. Among the regions studied were the cerebellum, which controls movement, and the cerebral cortex, which controls language and memory. The team found that methylation patterns differed by brain region, indicating that epigenetics helps divide up the brain's functions. These patterns proved more robust than differences in methylation linked to race, age, or sex, the team reports in the December issue of The American Journal of Human Genetics.
The study makes clear, Feinberg says, that "working on the brain without thinking about epigenetics is like working with a blindfold on." By understanding normal methylation, he adds, researchers can begin to look at methylation gone wrong, possibly in autism, depression, bipolar disease, and schizophrenia.
Given that epigenetics has been shown to modify gene expression in other parts of the body, the brain results are not surprising, says psychiatrist Schahram Akbarian of the University of Massachusetts Medical School in Worcester. "One could say neuroscience is catching up with the rest of the field."
Stocks Little Changed on Jobs Report
2007年12月6日星期四
BigFix Updates Core Systems Management Software
2007年12月5日星期三
Did Carbon Save Earth From a Deep Freeze?
By Phil Berardelli
ScienceNOW Daily News
5 December 2007
Life on Earth depends on the greenhouse effect. Without carbon dioxide and other gases in the atmosphere to capture a significant portion of the sun's heat, the planet would have plunged into subfreezing temperatures long ago--and perhaps never warmed enough to allow complex, heat-dependent creatures such as humans to flourish. Geological data show that Earth has come perilously close to this scenario in the distant past. One viewpoint, called the snowball Earth hypothesis, suggests that the planet required millions of years to recover from these deep freezes--the last one occurring about 550 million years ago--and could do so only via the accumulation of atmospheric carbon dioxide from volcanic eruptions.
Now a team from the University of Toronto in Canada has used a model of the carbon cycle to show that the presence of the element--in the form of a class of minerals called carbonates--in the sea bottom arrested the deep freeze before it completely overcame the planet. Instead of snowball Earth, the team reports in the 6 December issue of Nature, the effect was more of a "slushball Earth." The researchers, led by geophysicist W. Richard Peltier, found that cooling global temperatures allow the oceans to absorb more oxygen from the atmosphere. The oxygen reacts with carbonates deposited from the skeletons of tiny marine organisms as well as the action of photosynthesis by plankton, releasing carbon dioxide that helps temperatures bounce back quickly, at least on a geological timetable. The greenhouse effect has played an important role, "even in the deep past, in determining the surface climate of the planet," Peltier says. And from 1 billion years ago to about 550 million years ago, the period that was the subject of the study, "this influence apparently acted to protect the biosphere."
It is clear from the research that Earth's feedback systems kept the planet from plunging permanently into a snowball state, says geologist Alan Jay Kaufman of the University of Maryland, College Park. In principle, the feedback system might spare the planet from a runaway greenhouse effect if the oceans take up enough carbon from the atmosphere. But the effect takes place over many thousands of years, Kaufman says, so there's little hope that the carbon cycle could temper the effect of increased atmospheric CO2 on human time scales.
2007年12月4日星期二
CA Fires Another Shot Across Beacon's Bow
2007年12月3日星期一
Ads Coming to PDFs Courtesy of Adobe, Yahoo
2007年12月1日星期六
New Form of Cell Death Discovered
By Steve Mitchell
ScienceNOW Daily News
29 November 2007
For more than 25 years, scientists examining cultures of human cancer cells have occasionally spotted cells tucked within other cells. But the phenomenon remained largely unexplored until a team led by cell biologist Michael Overholtzer of Harvard Medical School in Boston recently saw the same thing while working with a line of normal breast cells. As in breast tissue, these cultured cells usually grow on a membrane or matrix. When they became detached, however, some cells appeared to be enveloped by other cells. Intrigued, the researchers looked closer.
Overholtzer's team found that up to 70%26#37; of the detached cells died once engulfed by another detached cell. However, up to 9%26#37; divided while enveloped and up to 18%26#37; were eventually released unharmed. Blocking the mechanisms involved in other methods of cell death including apoptosis and phagocytosis did not disrupt the process, confirming that entosis operates in a different way.
Further experiments revealed that cadherins, proteins that keep cells joined to each other, are required for entosis. The researchers are still working out the details, but they speculate in the 30 November issue of Cell that entosis occurs due to an imbalance in adhesion forces between two cells when they dislodge from the matrix. This could lead to one cell pushing into the other until it is engulfed, akin to pressing your fist into a balloon.
However entosis occurs, it appears to be widespread. The team found evidence of the process in several other cell types, including breast, ovarian, umbilical cord, and kidney cancer cells. Overholtzer says tumor suppression may be one function of entosis. When a chemical that inhibits entosis was applied to a line of breast cancer cells, colony formation--an indicator of tumor growth in vitro--increased 10-fold.
Conversely, cancer cells could be using entosis as a survival tool. It may be "a way for a tumor cell to escape recognition by chemotherapeutic drugs or the immune system" by hiding out inside another cell, says Maureen Murphy, a molecular biologist at Fox Chase Cancer Center in Philadelphia, Pennsylvania. That may explain why not all cells die during entosis.
Craig Thompson, a cancer biologist at the University of Pennsylvania, is more skeptical. The fact that some cells survive entosis, he says, suggests that it is not a very effective process for suppressing tumors and raises concern that it may be a phenomenon that primarily occurs in the lab rather than in the body.
Facebook Backpedals on Beacon
2007年11月28日星期三
Sell Boron Carbide
http://buy-or-sell.org/Chemicals/Sell-Boron-Carbide-MqVd0QPV/
2007年11月27日星期二
Taking a Page From the Book of Flight
By Phil Berardelli
ScienceNOW Daily News
27 November 2007
For centuries, scientists and inventors have been attempting--nearly always unsuccessfully--to adapt the graceful beatings of a bird's wings for mechanical flight. A flapping craft would have two main advantages over planes and helicopters: It could stay airborne over a wide range of speeds and would be more maneuverable, achieving both without sacrificing aerodynamic efficiency. Such abilities could be particularly useful for unmanned aerial vehicles (UAVs), the lightweight aircraft the military increasingly employs for low-altitude reconnaissance.
Researchers from Pierre and Marie Curie University in Paris embarked on a unique strategy to apply the secrets of bird flight. They created a program called an evolutionary algorithm that essentially "evolves" a birdlike creature from scratch, refining designs that work and tossing those that don't. The team then appropriated the most successful designs from the algorithm to create a simulated UAV. The simulation achieved a birdlike energy efficiency flying at speeds between 10 meters and 12 meters per second, the researchers report in the December issue of Bioinspiration and Biomimetics. Based on the tests, the team has built a mechanical prototype with the goal, says biologist and lead author Emmanuel de Margerie, of improving wing designs based on further refinements from the algorithm.
Evolutionary roboticist Inman Harvey of the University of Sussex, U.K., praises the team's artificial evolution approach. It allows the exploration of designs "that a human designer might not have considered venturing into," he says. Still, the team's findings are limited, says research engineer Robert Michelson of the Georgia Institute of Technology in Atlanta. He notes, for example, that the simulated UAV the researchers developed is only efficient at relatively high speeds; at lower speeds, flight efficiency drops dramatically. And despite its advantages, flapping flight has its share of kinks. The bouncing reduces the value of the craft as a camera platform, says Michelson, and flapping can place large strains on wings. So far, these "have been the long poles in the creation of flapping-wing micro air vehicles," he says.
ABS Plastics Fairings For Motor Cycles
http://buy.buy-or-sell.org/Automobile/ABS-Plastics-Fairings-For-Motor-Cycles-Jq0id7eC/
Cyber Monday Shopping Traffic Breaks Records, Sites
Sales up, but sites down? Record site traffic might be a victory for the marketing departments, but IT gets a mixed report card, according to Keynote Systems, a research firm that measures Web site performance. Just as on Black Friday, many e-commerce sites buckled under the weight of the traffic, which created significant slowdowns in product search and checkout. Brick-and-mortar retailers suffered the biggest problems, according to Keynote, with Toys "R" Us' site experiencing slowdowns of up to 300 percent, JCrew.com's transaction processing slowing by up to 400 percent, and Costco's site performance flagging by as much as 500 percent in periods of peak traffic. Yahoo's hosted shopping service, which Keynote does not track, also hit major snags due to heavy traffic. Yahoo hosts the e-commerce services for many smaller retailers, who found that their shopping cart services were unable to process transactions yesterday afternoon. Shortly after noon yesterday, Yahoo posted an acknowledgement on its Small Business site that shoppers had been receiving a "system unavailable" message when trying to checkout on some merchants' sites. At 9:51 p.m., Yahoo reported that after some reconfiguration, all merchants could process transactions, but some could expect slower-than-usual site performance. This morning, at 2:06 a.m., Yahoo reported that the issue had been resolved and that it was "actively monitoring all systems involved." Yahoo's problem may have been an anomaly, but Keynote's research suggests that the strain of heavy traffic on site performance is not, with site slowdowns also having taken place on Black Friday. However, even with Black Friday's difficulties, enough of the day's shoppers held on through the checkout process to post impressive numbers. Online shoppers spent $531 million on Black Friday, up 22 percent from last year, comScore has reported. On Thanksgiving, online retail spending rose 29 percent from last year to $272 million. The company also said that for the first 23 days of November (ending on Black Friday), online retail spending reached $9.36 billion, up 17 percent from the same period last year. And the hottest product segment so far this shopping season? Sales of video games, consoles and accessories are up 134 percent from last year, propelled in large part by hot items like the Nintendo Wii, Sony Playstation 3 and Halo 3, according to comScore.
Sell Nicotinic Acid
http://buy-or-sell.org/Chemicals/Sell-Nicotinic-Acid-80QyWyPd/
Gene Therapy Did Not Kill Patient, Study Finds
By Jocelyn Kaiser
ScienceNOW Daily News
26 November 2007
The trial conducted by Targeted Genetics Corp. was shut down after the 24 July death of 36-year-old Jolee Mohr of Taylorville, Illinois, who received a gene-therapy injection to treat her rheumatoid arthritis in one knee 3 weeks earlier (Science, 3 August). At a September meeting of the federal Recombinant DNA Advisory Committee (RAC), experts noted that Mohr apparently died mainly from a fungal infection called histoplasmosis that her immune system was unable to fight off (ScienceNOW, 17 September). Mohr's immune system may have been compromised by an arthritis drug she was taking, Humira, which blocks an inflammatory molecule called tumor necrosis factor %26alpha; (TNF-%26alpha;). The protein produced by the gene therapy is also a TNF-%26alpha; blocker, and if it spread beyond Mohr's knee, the combination with Humira may have left her vulnerable to the fungus.
That did not happen, according to Targeted Genetics. The company points to new test results from an investigation by the company and outside researchers, which were presented at the American College of Rheumatology annual meeting earlier this month. The level of TNF-%26alpha; blocker detected in Mohr's blood with a binding assay was "well within the normal range expected" from the dose of Humira she was taking, says President and CEO H. Stewart Parker. The new tests also ruled out the idea that the gene-therapy vector, adeno-associated virus, replicated in Mohr's body. Although DNA from the vector turned up in other tissues, the amounts were extremely low. Today, the company announced that the U.S. Food and Drug Administration has lifted the hold on the trial.
Others agree that the case is closed. "It does not look like the gene therapy played a role to the best of our knowledge," says physician Kyle Hogarth of the University of Chicago in Illinois, who treated Mohr and took part in the investigation. However, Hogarth questions whether it makes sense to enroll patients who are already taking TNF-%26alpha; blockers in the study, because it's difficult to distinguish between the effects of the gene-therapy product and the drugs. Parker disagrees, noting that rheumatologists say "there is a significant unmet need" for treatments for patients with joints that do not respond to the systemic drugs.
The company now plans to resume the trial of 127 patients but will not give a second dose to as many as 35 awaiting patients if they have a fever, as Mohr did. "We are being conservative," says Parker. She says the only change to the informed-consent document will be to note the earlier death. RAC will issue its final conclusions about the case at a meeting next week. RAC Chair Howard Federoff of Georgetown University in Washington, D.C., declined to comment in advance of the meeting.